Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
Authors
Keywords
Fibrosis, Anemia, Cirrhosis, Hemoglobin, Liver fibrosis, Liver diseases, Hepatitis C virus, Adverse events
Journal
PLoS One
Volume 10, Issue 9, Pages e0138503
Publisher
Public Library of Science (PLoS)
Online
2015-09-24
DOI
10.1371/journal.pone.0138503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Health Technology Assessment of Transient Elastography in Adult Liver Disease
- (2016) Rodney Steadman et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
- (2014) V. Saxena et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program
- (2014) Massimo Colombo et al. JOURNAL OF HEPATOLOGY
- Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
- (2013) L. I. Backus et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C
- (2013) Cristina Stasi et al. DIGESTIVE AND LIVER DISEASE
- Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
- (2013) M Colombo et al. GUT
- Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
- (2013) Stefan Mauss et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 65 SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE – PREDICTIVE FACTORS FOR SEPSIS
- (2013) K. Rutter et al. JOURNAL OF HEPATOLOGY
- Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Efficacy and safety of telaprevir (TVR) triple therapy in a ‘real-life’ cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment
- (2013) C. R. Werner et al. JOURNAL OF VIRAL HEPATITIS
- Management of HCV patients with cirrhosis with direct acting antivirals
- (2013) Vincenzo Boccaccio et al. LIVER INTERNATIONAL
- Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
- (2013) Benjamin Maasoumy et al. PLoS One
- Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives
- (2013) Beom Kyung Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
- (2012) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis
- (2012) Savino Bruno et al. JOURNAL OF HEPATOLOGY
- Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy
- (2012) Stella M. Martinez et al. PLoS One
- Liver stiffness diminishes with antiviral response in chronic hepatitis C
- (2011) C. Hézode et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C
- (2011) Julien Vergniol et al. GASTROENTEROLOGY
- Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study
- (2011) Marie Angèle Robic et al. JOURNAL OF HEPATOLOGY
- Transient elastography for predicting clinical outcomes in patients with chronic liver disease
- (2011) D. A. Klibansky et al. JOURNAL OF VIRAL HEPATITIS
- Future treatment of patients with HCV cirrhosis
- (2011) Marc Bourlière et al. LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Hepatitis C Infection
- (2011) Hugo R. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- FibroSURE™and FibroScan®in relation to treatment response in chronic hepatitis C virus
- (2011) Keyur Patel WORLD JOURNAL OF GASTROENTEROLOGY
- Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies
- (2010) Thierry Poynard et al. ANTIVIRAL THERAPY
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C
- (2010) Timothy R. Morgan et al. HEPATOLOGY
- Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C
- (2010) Yuko Arima et al. HEPATOLOGY RESEARCH
- Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin
- (2010) J. Macias et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy
- (2010) E.A. Tsochatzis et al. JOURNAL OF HEPATOLOGY
- Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy
- (2010) J. Mendoza et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
- (2009) Eiichi Ogawa et al. ANTIVIRAL RESEARCH
- Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan
- (2009) Jing-Houng Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Changes of non-invasive markers and FibroScan values during HCV treatment
- (2009) J. Vergniol et al. JOURNAL OF VIRAL HEPATITIS
- Non-invasive evaluation of liver fibrosis using transient elastography
- (2008) Laurent Castera et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started